#Erica mazaika ware trial#

Rovira i Virgili University - Hospital Universitario de Tarragona Joan XXIII Nathan Ingold Imperial College London - National Heart and Lung Institute Alfredo Bardaji Imperial College London - National Heart and Lung Institute Alicja Wilk Rovira i Virgili University - Hospital Universitario de Tarragona Joan XXIII William Midwinter

Imperial College London - National Heart and Lung Institute Isabel Serrano University of Pennsylvania - Perelman School of Medicine Josep LuponĬIBER in Cardiovascular Diseases (CIBERCV) Nicky Whiffin Imperial College London - National Heart and Lung Institute Brian Finkelman Imperial College London - National Heart and Lung Institute Antoni Bayes-GenisĬIBER in Cardiovascular Diseases (CIBERCV) Roddy Walsh Universidad Autónoma de Madrid - Hospital Universitario Puerta de Hierro-Majadahonda Erica Mazaika Imperial College London - National Heart and Lung Institute Beatriz Nuñez University of Pennsylvania - Perelman School of Medicine Risha Govind University of Pennsylvania - Perelman School of Medicine Anjali Owens University of Pennsylvania - Perelman School of Medicine Jian Li Harvard University - Harvard Medical School Zoltan Arany Harvard University - Harvard Medical School Jonathan A. Harvard University - Harvard Medical School Kaoru Ito Harvard University - Harvard Medical School Parth Patel Harvard University - Harvard Medical School Kelly Getz University of Pennsylvania - Perelman School of Medicine Christopher N. Harvard University - Harvard Medical School Amanda M. Harvard University - Harvard Medical School Hiroko Wakimoto Universidad Autónoma de Madrid - Hospital Universitario Puerta de Hierro-Majadahonda Ida G. Harvard University - Harvard Medical School Alejandra Restrepo-Cordoba Hospital Universitario Puerta de Hierro-Majadahonda, Department of Cardiology, Heart Failure and Inherited Cardiac Diseases Unit CIBER in Cardiovascular Diseases (CIBERCV) Francisco de Vitoria University Yuri Kim See all articles by Pablo Garcia-Pavia Pablo Garcia-Pavia

#Erica mazaika ware trial#

For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact Genetic Predisposing Variants Associated with Cancer Therapy-Induced Cardiomyopathy The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. These preprints are early stage research papers that have not been peer-reviewed. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication.